Arterra Bioscience S.p.A. (BIT:ARBS)
2.840
+0.010 (0.35%)
Jun 15, 2026, 5:54 PM CET
Arterra Bioscience Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.34 | 3.34 | 3.69 | 4.39 | 4.81 |
Trading Asset Securities | - | - | - | 1.6 | - |
Cash & Short-Term Investments | 1.34 | 3.34 | 3.69 | 5.99 | 4.81 |
Cash Growth | -59.84% | -9.29% | -38.48% | 24.46% | 6.13% |
Accounts Receivable | 1.86 | 1.63 | 1.06 | 0.77 | 1.47 |
Other Receivables | 2.11 | 1.98 | 1.78 | 1.88 | 1.71 |
Receivables | 3.97 | 3.61 | 2.84 | 2.65 | 3.19 |
Inventory | 1.54 | 1.33 | 1.36 | 1.16 | 0.49 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 6.88 | 8.29 | 7.89 | 9.81 | 8.49 |
Property, Plant & Equipment | 1.68 | 1.51 | 1.23 | 1.54 | 1.66 |
Long-Term Investments | 5.92 | 3.45 | 3.35 | 0.98 | 0.95 |
Other Intangible Assets | 0.02 | 0.03 | 0.04 | 0.05 | 0.13 |
Long-Term Deferred Charges | 0 | 0 | - | 0.15 | 0.31 |
Other Long-Term Assets | 0.09 | 0.11 | 0.04 | 0.04 | 0.04 |
Total Assets | 14.59 | 13.4 | 12.55 | 12.57 | 11.58 |
Accounts Payable | 0.24 | 0.28 | 0.25 | 0.19 | 0.25 |
Accrued Expenses | 0.46 | 0.31 | 0.43 | 0.32 | 0.69 |
Current Portion of Long-Term Debt | 0.09 | 0.1 | 0.09 | 0.17 | 0.22 |
Current Income Taxes Payable | - | - | - | 0.23 | 0.02 |
Other Current Liabilities | 0.09 | 0.14 | 0.08 | 0.24 | 0.05 |
Total Current Liabilities | 0.88 | 0.82 | 0.84 | 1.16 | 1.23 |
Long-Term Debt | 0.17 | 0.26 | 0.3 | 0.32 | 0.39 |
Long-Term Deferred Tax Liabilities | 0.39 | 0.38 | 0.22 | 0.24 | 0.2 |
Other Long-Term Liabilities | 0.57 | 0.52 | 0.44 | 0.39 | 0.29 |
Total Liabilities | 2.01 | 1.98 | 1.8 | 2.1 | 2.11 |
Common Stock | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 |
Additional Paid-In Capital | 4.17 | 4.17 | 4.17 | 4.17 | 4.17 |
Retained Earnings | 8.41 | 7.25 | 6.58 | 6.17 | 5.08 |
Treasury Stock | -0.33 | -0.33 | -0.33 | -0.2 | -0.11 |
Shareholders' Equity | 12.58 | 11.42 | 10.75 | 10.47 | 9.47 |
Total Liabilities & Equity | 14.59 | 13.4 | 12.55 | 12.57 | 11.58 |
Total Debt | 0.26 | 0.36 | 0.39 | 0.49 | 0.61 |
Net Cash (Debt) | 1.08 | 2.99 | 3.3 | 5.5 | 4.2 |
Net Cash Growth | -63.77% | -9.48% | -40.03% | 31.02% | 12.69% |
Net Cash Per Share | 0.16 | 0.45 | 0.50 | - | - |
Filing Date Shares Outstanding | 6.66 | 6.66 | 6.66 | - | - |
Total Common Shares Outstanding | 6.66 | 6.66 | 6.66 | - | - |
Working Capital | 6 | 7.47 | 7.04 | 8.65 | 7.26 |
Book Value Per Share | 1.89 | 1.72 | 1.61 | - | - |
Tangible Book Value | 12.56 | 11.39 | 10.71 | 10.42 | 9.34 |
Tangible Book Value Per Share | 1.89 | 1.71 | 1.61 | - | - |
Land | 1.15 | 1.09 | 0.72 | 0.72 | 0.61 |
Machinery | 2.92 | 2.57 | 2.43 | 2.41 | 2.61 |
Construction In Progress | 0.02 | 0.01 | - | - | 0.01 |